PVLAPalvella Therapeutics Inc. Common Stock
142.04USD-5.28%Mkt Cap: 2.05B $P/E: —3d ago
Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product cand…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.05B $
Enterprise Value1.83B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-41.72M $
Revenue/Share—
Last Price142.04 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-19.02
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B9.46
EPS (TTM)-4.62
EPS (Forward)-7.50
52W Range
46.0883% of range161.38
52W High161.38 USD
52W Low46.08 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-149.07%
ROA-70.04%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.01M $
CapEx (TTM)—
FCF Margin—
FCF Yield-1.24%
Net Debt-227.94M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.02
Current Ratio21.18
Quick Ratio21.01
Book Value/Sh15.06 USD
Cash/Share17.39 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:80
Split DateApr 23, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)230.53 USD
Upside (mean)+62.3%
Target Range205.00 USD – 270.00 USD
$205.00+62.3% to mean$270.00
# Analysts15
Ownership
Shares Out.14.41M
Float10.62M
Insiders11.59%
Institutions103.07%
Short Interest
Short Ratio8.5d
Short % Float16.24%
Short % Out.14.36%
Shares Short2.07M
Short (prev mo.)2.37M
Technical
SMA 50140.66 (+1.0%)
SMA 200114.93 (+23.6%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)198.34K
Avg Vol (10d)179.16K
Technical Indicators
RSI (14)45.5
MACD3.0215
MACD Signal4.2567
MACD Hist.-1.2352
BB Upper162.37 USD
BB Middle148.89 USD
BB Lower135.42 USD
BB Width18.10%
ATR (14)9.163 USD
Vol Ratio (20d)0.97x